If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
120.50    1.50 (1.26%)
Bid:
119.00
Ask:
120.00
Spread: 1.00 (0.84%)
Market Cap: £94.56m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Year end trading update

10 Jan 2008 07:01

Xaar PLC10 January 2008 FOR IMMEDIATE RELEASE 10 January 2008 Xaar plc FULL YEAR TRADING UPDATE Xaar plc ("Xaar"), the inkjet printing technology group headquartered in Cambridge, presents an update on performance for the year to 31 December 2007. Trading Revenue for the year is expected to be approximately £47.9m, an increase of 13% over the prior year. Growth in the company's existing Platform 1 products was solid whilst interest in the latest Platform 3 product, the Xaar1001, continues to grow. Profit before tax for the year was approximately £7.3m (31 December 2006: £6.9m)which was in line with the IFRS compliant market consensus figure. Profit for the year is stated after charging amortisation of capitalised R&D of £1.0m (31 December 2006: £0.5m), the cost of share options of £0.9m (31 December2006: £0.7m) and the fixed cost of the new Huntingdon facility which was within expectations at £2.5m (31 December 2006: £nil). Before the cost of the Huntingdon operation, profit before tax for the year increased by 42% over the prior year. As previously noted, take-up of Platform 2 products remains slower than originally expected but the company was pleased to see the recent launch of the Teckstorm and Teckthunder wide format printers from Teckwin Development Co. Ltd.based on the Xaar 760; other wide format printers incorporating the Xaar 760 areexpected to be launched in the coming months. There are now a significant number of evaluation kits for the Platform 3, Xaar 1001, on test with existing and potential customers and several equipment launches incorporating the printhead are expected in 2008. Drupa, the industry'spremier printing trade exhibition held every four years in Germany, will take place in May 2008; equipment launches are often timed to coincide with the show. Importantly, these equipment launches are expected to be in new markets for Xaaras the company presses home its technology advantage by leading the move of inkjet printing into mainstream commercial printing applications. One machine which has already been announced is the 'Caslon' narrow web label press from Nilpeter, the world's leading manufacturer of this type of press. A second narrow web label press from a large US printing technology group is due to be announced shortly. Commercial sales of both of these machines are expected to begin in the first half of 2008. Cash Cash at the end of December was approximately £13.0m (31 December 2006: £12.4m, 30 June 2007: £10.0m). This reflects the payment of the final dividend for 2006 of £1.2m and capital expenditure on tangible and intangible assets of approximately £5.4m. Dividend It is the Board's intention to recommend payment of a final dividend for the year of 2.5p, representing an increase of 25% over the final dividend for 2006. This increase reflects the Board's confidence in the future profitability and cash generation of the business. With effect from 2008 it is the Board's intention, subject to satisfactory performance, to introduce payment of an interim as well as a final dividend. Outlook The Board remains confident about the prospects for 2008 and beyond. After several years of rapid growth, third party forecasts now suggest that demand in the company's core graphic arts market will mature to a steady annual percentage growth rate in high single figures. Meanwhile, forecasts for the newer Platform 2 and Platform 3 products suggest demand will build as the year progresses. Announcement of final results The detailed results for 2007 will be announced in accordance with Xaar's normaltimetable on 13 March 2008. Ends Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & DeputyChief Executive Bankside Consultants:Steve Liebmann or Simon Bloomfield 020-7367-8883 / 07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.